General Chapter on Inorganic Impurities: Heavy Metals
USP Ad Hoc Advisory Panel on Inorganic Impurities and Heavy Metals and
USP Staff*
The following Stimuli article is provided to interested parties in advance of publishing in the September-October Pharmacopeial Forum 34(5). You may nd comments on this article to Kahkashan Zaidi, PhD, Senior Scientist, Documentary Standards Division, US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790; tel. 301.816.8269; e-mail kxz@usp. The deadline for comments is December 15, 2008.
ABSTRACT In the ICH Q3A Impurities in Drug Substances guidance, impurities are classified as organic, inorganic, and residual solvents. Within the inorganic impurities classification, the metals listed in Table 1 are important to control in food, dietary supplements, and drug articles. Many toxic metal imp
urities found in pharmaceutical articles have been controlled for years by application of the Heavy Metals test described in USP–NF General Chapter Heavy Metals
铁皮石斛主治什么<231>. However, the procedures and the methods contained in <231> lack the nsitivity, specificity, and recovery to monitor properly the levels of the metals. A number of additional chapters for the control of specific metals and other inorganic impurities are contained in USP–NF. This Stimuli article propos a new USP General Chapter for the control of inorganic impurities in drug and dietary supplement articles intended for u in humans. For the purpos of this article, inorganic impurity, metal, and element all refer to tho elements listed in Table 1. The propod new General Chapter recommends procedures that rely on modern analytical technology and includes limits that are bad on toxicity and exposure levels for the lected metals. The new General Chapter also introduces a performance-bad approach for the lection of the appropriate technology. This chapter is propod to replace <231> and may impact other General Chapters that control metals.
INTRODUCTION
Among the category of inorganic impurities, metal impurities have long been monitored in food and drug articles intended for consumption by humans and other animals. For purpos of this General
Chapter, drug articles include: drug substances and products (including natural-source and rDNA biologics) and excipients. Dietary supplements and their ingredients are also included, but other foods and food ingredients will not be addresd. Some metals may po no significant health hazard at sufficiently low exposure levels, when prent as certain complexes, at certain oxidation states, or in organic combinations. This chapter should be considered a screening method to identify the prence of potentially hazardous elements. Where speciation of an element is important, further testing is necessary. In the cas, the monograph will include specific instructions for appropriate identification and control. The topic of speciation will not be covered further in this article.
Some inorganic impurities are toxic at low levels, and the impurities should be monitored to ensure safety. Sources of inorganic impurities include tho that are deliberately added to the process (e.g., catalysts), tho that are carried through a process that is conducted according to good manufacturing practices (e.g., undetected contaminants from starting materials or reagents), tho coming from the process (e.g., leaching from pipes and other equipment), and tho that朴美宣
control of the impurities may be certified by a vendor, but purchars also must corroborate the abnce of impurities before using the materials in a manufactured article.
The General Chapters Expert Committee of the USP Council of Experts formed an Ad Hoc Advisory Panel on Inorganic Impurities and Heavy Metals to assist the Expert Committee in revision of General Chapter Heavy Metals <231>. As drafted by this Ad Hoc Advisory Panel and revid by the Expert Committee, the propod revision specifies that the level of each inorganic impurity should not exceed the limit defined in Table 1 or otherwi specified in the individual monograph. This level is determined by concomitant comparison with a monitor solution and USP Reference Standard solution(s).
The lection of an instrumental technique and a procedure for the evaluation of the inorganic impurities specified in Table 1 requires the evaluation of a large number of variables including, among others, nsitivity, precision, accuracy, compatibility, time, and cost. The method lected may include plasma spectrochemistry, atomic absorption spectroscopy, or any other method that displays requisite accuracy (trueness and uncertainty) and established nsitivity and specificity. Meeting this requirement must be demonstrated experimentally using the USP Reference Standard(s). Any procedure that provides measurement values within ± 20% of the certified concentration for each element in the appropriate USP Reference Standard(s) is considered to be an acceptable procedure to demonstrate compliance. A guide for the lection of a procedure is pres
ented in Figure 1. When a manufacturer does not have a preferred procedure, or when the preferred procedure does not meet criteria for performance described above, proceed as directed in the remainder of this General Chapter.
Procedure—Determine the levels of individual inorganic impurities by the test, unless the individual monograph specifies otherwi.
Reagents—All reagents ud for the preparation of sample and standard solutions should be free of inorganic impurities in accordance with Plasma Spectrochemistry <730>. Commercial, National Institute of Standards and Technology–traceable elemental stock standards, either single element or multi-element, containing Al, Sb, As, Be, B, Cd, Cr, Co, Cu, In, Ir, Fe, Pb, Li, Mg, Mn, Hg, Mo, Ni, Os, Pd, Pt, Rh, Rb, Ru, Se, Sr, Tl, Sn, W, or Zn at a recommended concentration of 100 µg/mL or greater also are ud as reagents.
手机种类Performance-bad USP Reference Standards—
烧心最快解决方法
USP Inorganic Impurities Class 1 Reference Standard for test articles soluble in aqueous solutions.
USP Inorganic Impurities Class 2 Reference Standard for test articles soluble in organic solvents.
USP Inorganic Impurities Class 3 Reference Standard for clod-vesl microwave digestions. Equipment—One of the following plasma spectrometers is required for an analyst to perform this multi-element analysis:
广东省省会
1. Inductively coupled plasma–atomic (optical) emission spectrometer.
2. Inductively coupled plasma–mass spectrometer.
In addition, a clod-vesl microwave digestion system may be required for the preparation of test materials (e Figure 1).
METHOD
Sample Preparation
Determine the means of sample preparation using the flow chart in Figure 1. The sample preparation scheme should provide sufficient sample loading to allow quantification of each element at the specified limit stated in the corresponding monograph or as stated in Table 1. For clod-vesl microwave digestions follow the manufacturer’s recommended procedures to ensure safe usage. U utmost caution if concentrated hydrofluoric acid (HF) is ud for the preparation of test articles,
and review or establish local procedures for safe handling, safe disposal, and HF-tolerant instrumental configurations. [NOTE: The specific details of the Sample preparation have not been included in this Stimuli article but have been developed by the Ad Hoc Advisory Panel. The decision to exclude the specific method details from the Stimuli article is bad on the desire of the Ad Hoc Advisory Panel to receive feedback on the concepts propod herein rather than on the specific method. Bad on the feedback received, the details may be included in future chapter development.]
System Suitability Criteria—
生日感慨
Method reporting limit
The method reporting limit (MRL) is defined as the lowest element concentration of a solution prepared in the working calibration standard matrix that can be experimentally determined to within ± 30% of the prepared concentration. The nsitivity criterion for the method is that the MRL is 0.5 × the USP limit for each applicable element.
Recovery
The suitability of the sample preparation scheme must be demonstrated by preparation and analysis of a suitable USP Reference Standard and by spike recovery measurements of the specific test article according to <730>. The spiked test article solution will be referred to as a Monitor solution. The experimental concentration results shall be ± 20% of the certified concentration for each required element in the analysis. The spike recovery results for the Monitor solution must be ± 20% of the spike concentration for each element. Analysis of a suitable USP Reference Standard shall be included with the analys of test articles and must be within ± 20% of the certified concentration for each required element for the results to be considered acceptable.
Calibration
Prepare calibration standards in the same solution as ud for preparation of the test articles. Analysts are encouraged to u internal standards according to <730> for preparation of test article and calibration standard solutions. Prepare 4 working standards plus a blank at element concentrations encompassing the required USP limits for the test article, the USP Reference Standard, and the Monitor solution. Standard curve acceptance criteria must be met according to <730>. If the concentration of an element in the test article solution is determined to be greater than 110% of the highest calibration standard concentration, the test article solution should be appropriate
ly diluted within the range of the standard curve and then reanalyzed.
Drift
To monitor instrument drift, analyze a working standard solution at an intermediate concentration of each element immediately following standardization, following the final test solution, and during the analysis at a frequency of one working standard solution analysis per not more than 10 sample analys during the analytical run. The check standard results should agree
test article solutions that are not bracketed with results within the tolerance for the check standard.
Analysis [NOTE: The specific details of the methods have not been included in this Stimuli article but have been developed by the Ad Hoc Advisory Panel. The decision to exclude the specific method details from the Stimuli article is bad on the desire of the Ad Hoc Advisory Panel to receive feedback on the concepts propod herein rather than on the specific method. Bad on the feedback received, the details may be included in future chapter development.] Calculations and Reporting—
溶血性黄疸Upon completion of the analysis, calculate the final concentration of a given element in the test article in µg/g from the solution element concentration in μg/mL as follows:
C = [(A×V1)/W] × (V2/V3)
where:
C = concentration of analyte in μg/g,
A = instrument reading in μg/mL,
V1 = volume of initial test article preparation,
W = weight of test article preparation in g,
V2 = total volume of any dilution performed in mL, and
V3 = aliquot of initial test article preparation ud in any dilution performed in mL. Similarly, calculate the final concentration of a given element in the test article in µg/g from the solution element concentration in ng/mL as follows:
C = [(A × V1)/W] × (1 μg/1000 ng)(V2/V3)
where:
C = concentration of analyte in μg/g,
A = instrument reading in ng/mL,
V1 = volume of initial test article preparation,
W = weight of test article preparation in g,
V2 = total volume of any dilution performed in mL, and
V3 = aliquot of initial test article preparation ud in any dilution performed in mL. Calculate the results for each analyte, and compare the values obtained for the test article to tho provided in Table 1. The results should not exceed the values in the table.
什么是生态文明
CONCLUSION
The USP Ad Hoc Advisory Panel on Inorganic Impurities and Heavy Metals invites comments on the recommendations regarding the u of appropriate analytical instrumentation with limits that are bad on toxicity and exposure levels for the metals and the new approach for the determination of an appropriate analytical procedure by the application of USP Reference Standards described in this
Stimuli article. Plea nd detailed comments to: Kahkashan Zaidi, PhD, Senior Scientist, Documentary Standards Division, US Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790; tel. 301.816.8269; e-mail kxz@usp.
Figure 1. Inorganic impurity decision tree.
